{
  "author": {
    "name": "Sarah Varney",
    "webUrl": "/author/profile/sarah-varney/",
    "description": "",
    "imageLarge": "https://secure.gravatar.com/avatar/f16d6fc2845f417ea0e93a3f2b6cd37d?s=136&d=mm&r=g",
    "estimate": 4,
    "social": [],
    "articles": [
      {
        "uri": "/2024/03/26/at-stake-in-mifepristone-case-abortion-fdas-authority-and-return-to-1873-obscenity-law/",
        "title": "Supreme Court to hear abortion pill case, challenging FDA's strict safety limits",
        "byline": "Sarah Varney, KFF Health News",
        "kicker": "News",
        "prettyDate": "March 26, 2024",
        "timeToRead": "7 minute",
        "image": {
          "uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2024/03/Supreme-Court-Courtroom-Article-202312131025.jpg",
          "width": "620",
          "height": "372"
        },
        "authors": [
          {
            "webUrl": "/author/profile/sarah-varney-kff-health-news/",
            "name": "Sarah Varney, KFF Health News"
          }
        ],
        "kickerNode": [
          {
            "uri": "/news/",
            "sectionName": "News"
          }
        ],
        "summary": "On Tuesday, the justices will hear arguments on whether to revoke mifepristone's approval and curtail its availability because the FDA  imposed strict safety limits on who could prescribe and distribute it when it gave its approval.",
        "body": null
      },
      {
        "uri": "/2023/03/20/access-to-abortion-pill-in-the-balance-awaiting-texas-federal-judges-decision/",
        "title": "Access to abortion pill in the balance, awaiting Texas federal judge's decision",
        "byline": "Sarah Varney",
        "kicker": "Update",
        "prettyDate": "March 20, 2023",
        "timeToRead": "6 minute",
        "image": {
          "uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2022/08/0922-Abortion-1-2.jpg",
          "width": "1000",
          "height": "554"
        },
        "authors": [
          {
            "webUrl": "/author/profile/sarah-varney/",
            "name": "Sarah Varney"
          }
        ],
        "kickerNode": [
          {
            "uri": "/update/",
            "sectionName": "Update"
          }
        ],
        "summary": "Last week, the judge heard arguments in a case that will decide the safety of mifepristone, one of the drugs in the two-pill regimen that has been used by 5.6 million women since 2000, according to the FDA.",
        "body": null
      },
      {
        "uri": "/2022/03/10/companies-are-closing-up-shop-in-russia-except-big-pharma/",
        "title": "Companies are closing up shop in Russia... Except Big Pharma",
        "byline": "Sarah Varney, Kaiser Health News",
        "kicker": "News",
        "prettyDate": "March 10, 2022",
        "timeToRead": "7 minute",
        "image": {
          "uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2022/03/Ukraine-Article-202203101002.jpg",
          "width": "558",
          "height": "372"
        },
        "authors": [
          {
            "webUrl": "/author/profile/sarah-varney-kaiser-health-news/",
            "name": "Sarah Varney, Kaiser Health News"
          }
        ],
        "kickerNode": [
          {
            "uri": "/news/",
            "sectionName": "News"
          }
        ],
        "summary": "The reluctance of drugmakers to pause operations in Russia is being met with a growing chorus of criticism.",
        "body": null
      },
      {
        "uri": "/2019/09/02/under-scrutiny-in-u-s-opioid-makers-see-profit-potential-in-india/",
        "title": "Under scrutiny in U.S., opioid makers see profit potential in India",
        "byline": "Sarah Varney, Kaiser Health News",
        "kicker": "Market Insights",
        "prettyDate": "September 02, 2019",
        "timeToRead": "11 minute",
        "image": {
          "uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2019/01/12BitterPill.jpg",
          "width": "616",
          "height": "372"
        },
        "authors": [
          {
            "webUrl": "/author/profile/sarah-varney-kaiser-health-news/",
            "name": "Sarah Varney, Kaiser Health News"
          }
        ],
        "kickerNode": [
          {
            "uri": "/market-insights/",
            "sectionName": "Market Insights"
          }
        ],
        "summary": "As major pharmaceutical companies look to capitalize on the opportunity, the playbook unfolding in India seems eerily familiar.",
        "body": null
      }
    ]
  }
}